Deal Capsule - October 2017 | KPMG | DE

Deal Capsule - October 2017

Deal Capsule - October 2017

M&A activity remains solid in life sciences.

1000

Contact

Partner, Head of Chemicals & Pharmaceuticals

KPMG AG Wirtschaftsprüfungsgesellschaft

Contact

Related content

Reagenzgläser

Theme of this issue:

M&A activity remains solid in life sciences with a high number of announced deals, although deal values are not expected to hit the heady levels of 2014 and 2015. Oncology drives M&A in life sciences as key players seek to optimize their portfolios in anticipation of 10.9% CAGR growth to 2030. Chemical companies are increasingly focussing their M&A on application industries. Agrochemicals remains an M&A hotspot. The closing of the DowDuPont merger brought with it a spate of anti-trust divestments. US and China remain the most active countries in both sectors.

Online version

Browse directly through the publication

© 2017 KPMG AG Wirtschaftsprüfungsgesellschaft, ein Mitglied des KPMG-Netzwerks unabhängiger Mitgliedsfirmen, die KPMG International Cooperative (“KPMG International”), einer juristischen Person schweizerischen Rechts, angeschlossen sind. Alle Rechte vorbehalten.

Connect with us

 

Request for proposal

 

Submit